Back to search results

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Liver Fibrosis · Hepatic Cirrhosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Research Site, Chandler, Arizona, United States

  • Research Site, Tucson, Arizona, United States

  • Research Site, Jupiter, Florida, United States

  • Research Site, Miami, Florida, United States

  • Research Site, Port Orange, Florida, United States

  • Research Site, Kansas City, Missouri, United States

  • Research Site, St Louis, Missouri, United States

  • Research Site, Las Vegas, Nevada, United States

  • Research Site, Morehead City, North Carolina, United States

  • Research Site, Raleigh, North Carolina, United States

  • Research Site, Westlake, Ohio, United States

  • Research Site, Yukon, Oklahoma, United States

  • Research Site, Clarksville, Tennessee, United States

  • Research Site, Austin, Texas, United States

  • Research Site, Denison, Texas, United States

  • Research Site, Georgetown, Texas, United States

  • Research Site, Houston, Texas, United States

  • Research Site, Houston, Texas, United States

  • Research Site, San Antonio, Texas, United States

  • Research Site, San Antonio, Texas, United States

View source on ClinicalTrials.gov(opens in a new tab)